As of 2026-08-16, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (14.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -744.1%.
The range of the Relative Valuation is (9.13) - (19.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 20.3x | 12.8x |
| Forward P/E multiples | 8.3x - 17.7x | 13.4x |
| Fair Price | (9.13) - (19.33) | (14.36) |
| Upside | -509.3% - -966.7% | -744.1% |
| Date | P/E |